รอสักครู่...
HEFEI, China, June 28, 2024 /PRNewswire/ -- Recently, Sungrow Hydrogen has won the biding of China Energy Engineering Corporation(CEEC) Songyuan Hydrogen Energy Industrial Park project in Jilin China,...
Read More
WELLINGTON, New Zealand, June 28, 2024 /PRNewswire/ -- Recently, the 2024 Ningbo City Image Exhibition was held at the Miramar Creative Centre in Wellington, New Zealand. The city image film "Ningbo" ...
Read More
SHENZHEN, China, June 28, 2024 /PRNewswire/ -- A grand event brought the attention of people from various industries, such as technology, finance, fashion, real estate, and culture, to Futian, Shenzhe...
Read More
SINGAPORE, June 28, 2024 /PRNewswire/ -- CapBridge Pte Ltd ("CapBridge"), a leading investment syndication and financial products platform and a member of FOMO Global Holdings Pte Ltd ("FOMO Group" or...
Read More
LONDON, June 26, 2024 /PRNewswire/ -- Released today, the IGU's 15th annual World LNG Report finds that global LNG trade grew by 2.1% in 2023, surpassing 401 million tonnes (MT). This global market no...
Read More
FREMONT, Calif., June 26, 2024 /PRNewswire/ -- YES (Yield Engineering Systems, Inc.), a leading manufacturer of process equipment for semiconductor advanced packaging applications, today announced tha...
Read More
HYDERABAD, India, June 26, 2024 /PRNewswire/ -- Fun88, the leading online gaming and sports betting platform, is thrilled to announce an exclusive offer for cricket enthusiasts and sports betting fans...
Read More
HONG KONG, June 26, 2024 /PRNewswire/ -- Sino Group is pleased to announce that Sino Land Company Limited ('Sino Land'; Stock Code: 0083.HK) has been named one of the World's Most Sustainable Companie...
Read More
5G enabling growing numbers of FWA service providers to offer speed-based tariff plans 5G subscriptions forecast close to 5.6 billion by the end of 2029 Mobile data traffic expected to grow by ...
Read More
- XPOVIO® is the first XPO1 inhibitor approved for reimbursement by South Korea's National Health Insurance Service (NHIS) for the treatment of adult patients with relapsed/refractory multiple myeloma...
Read More
ภาษาไทย
English